Ghana Targets Free Sickle Cell Treatment and Nationwide Genotype Screening to Curb Rising Cases

Ghana is intensifying its national response to Sickle Cell Disease (SCD) as policymakers and health advocates push for free treatment and mandatory genotype screening to address the condition's high prevalence. With approximately 18,000 to 20,000 babies born with the disease annually—representing one in every 60 births—stakeholders are calling for a fundamental shift in healthcare financing. During recent World Sickle Cell Awareness Day commemorations, leaders from the Ghana Health Service (GHS), Parliament, and academic institutions emphasized that the social and economic burden of the disease necessitates a more aggressive public health strategy to improve patient outcomes and reduce new infections.

Dr. Mark Kurt Nawaane, Chairman of Parliament’s Health Committee, has expressed optimism that Ghana is moving toward fully free treatment for SCD as part of broader healthcare reforms. A critical step in this direction has been the inclusion of hydroxyurea on the National Health Insurance Authority (NHIA) medication list, which provides life-altering treatment to thousands. Dr. Nawaane also highlighted the 'Mahama Care' initiative, which aims to cover complications related to the disease and integrate screening into primary healthcare. He further advocated for the establishment of specialized, designated hospitals for sickle cell management to ensure continuity of care and eliminate the current high costs faced by families at private facilities.

At the institutional level, the Kwame Nkrumah University of Science and Technology (KNUST) and the Focus on Sickle-Cell Foundation (FoSCel) are leading the charge for genotype awareness among the youth. Professor Christian Agyare, Vice-Chancellor designate of KNUST, underscored the 'profound impact' of SCD on education and economic productivity, urging young people to make informed reproductive choices. FoSCel founder Amos Andoh noted that by promoting genotype testing and responsible family planning, the foundation aims to significantly reduce new cases by 2030. They are calling for the decentralization of testing services to ensure that rural populations have equal access to screening and counseling.

The Ghana Health Service (GHS) continues to prioritize early diagnosis and the eradication of stigma surrounding the disease. Dr. Akosua Gyimah Omari-Sasu of the GHS noted that while roughly 2% of babies are born with sickle cell traits, early detection allows for medical interventions that prevent severe complications and premature death. By combining public-private partnerships with bold national policies, Ghana aims to transition from mere awareness to a comprehensive healthcare model that guarantees quality care for all individuals living with sickle cell disease.